Oestrogen-based drug could help in schizophrenia

woman gazes out of window
Internationally recognised scientists, Prof Cyndi Shannon Weickert and Dr Tom Weickert have recently reported that the drug raloxifene - an oestrogen-based medication - already used in the treatment of cancer and osteoporosis in women, improves the thinking ability, attention, and memory, in both men and women with schizophrenia. “First we found that oestrogen activity might

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Menzies Institute welcomes MRFF
Next Dentists disappointed by Budget 2015